Kadensa Capital’s CVS Health CVS Stock Holding History

Kadensa Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-800,000	Closed	-$35.9M	–	63
2024 Q4	$35.9M	Buy	+800,000	New	+$44.9M	4.36%	7

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kadensa Capital's CVS Position: Q1 2025 in Review

Kadensa Capital sold out of CVS Health (CVS) in Q1 2025, closing a stake of 800,000 shares — an estimated $35.9M sold.

Kadensa Capital first reported a position in CVS in Q4 2024 and held it in 1 quarter. The position peaked at $35.9M in Q4 2024. 1,752 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

Kadensa Capital reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
Kadensa Capital sold 800,000 CVS Health shares in Q1 2025, an estimated $35.9M.
Kadensa Capital first reported a position in CVS Health in Q4 2024 and held it in 1 quarter.
Kadensa Capital's CVS Health position peaked at $35.9M in Q4 2024.
1,752 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Kadensa Capital's 13F filing for Q1 2025, filed 15 May 2025.